PFS Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28K Hold
657
0.01% 269
2026
Q1
$41.2K Hold
657
0.02% 196
2025
Q4
$62.6K Hold
657
0.03% 158
2025
Q3
$64.1K Hold
657
0.03% 151
2025
Q2
$70.6K Hold
657
0.04% 135
2025
Q1
$66.3K Buy
657
+100
+18% +$10.1K 0.04% 129
2024
Q4
$49.8K Hold
557
0.03% 148
2024
Q3
$46.7K Hold
557
0.03% 141
2024
Q2
$42.9K Buy
+557
New +$40.8K 0.03% 133

Other funds holding BSX

PFS Partners's BSX Position: Q2 2026 in Review

PFS Partners held its Boston Scientific (BSX) position steady in Q2 2026 at 657 shares worth $28K. The position accounts for 0.01% of the portfolio, ranked #269.

PFS Partners first reported a position in BSX in Q2 2024 and has held it in 9 quarters since. The position peaked at $70.6K in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • PFS Partners held 657 shares of Boston Scientific worth $28K as of Q2 2026.
  • PFS Partners left its Boston Scientific share count unchanged in Q2 2026.
  • Boston Scientific made up 0.01% of PFS Partners's portfolio in Q2 2026, its #269 holding.
  • PFS Partners first reported a position in Boston Scientific in Q2 2024 and has held it in 9 quarters since.
  • PFS Partners's Boston Scientific position peaked at $70.6K in Q2 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.